Benard O. Ogola

Benard O. Ogola

Auto-generated profile, based on publicly available information

Benard O. Ogola

Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, 70112, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2019 in Biology of Sex Differences
Verified
Journal Article
Open access
PDF file
DHDillion Hutson
Dillion Hutson
RGRakesh Gurrala
Rakesh Gurrala
BOBenard O. Ogola
Benard O. Ogola
MZMargaret Zimmerman
Margaret Zimmerman
RMRicardo Mostany
Ricardo Mostany
SLSarah Lindsey
Sarah Lindsey
Estrogen is formed by the enzyme aromatase (CYP19A1) and signals via three identified receptors ERα (ESR1), ERß (ESR2), and the G protein-coupled estrogen receptor (GPER). Understanding the relative contribution of each receptor to estrogenic signaling may elucidate the disparate effects of this sex hormone across tissues, and recent developments in PCR technology allow absolute quantification and direct comparison of multiple targets. We hypothesized that this approach would reveal tissue- and sex-specific differences in estrogen receptor mRNA. ESR1, ESR2, GPER, and CYP19A1 were measured in four cardiovascular tissues (heart, aorta, kidney, and adrenal gland), three brain areas (somatosensory cortex, hippocampus, and prefrontal cortex), and reproductive tissues (ovaries, mammary gland, uterus, testes) from six male and six female adult Sprague-Dawley rats. GPER mRNA expression was relatively stable across all tissues in both sexes, ranging from 5.49 to 113 copies/ng RNA, a 21-fold difference. In contrast, ESR1/ESR2 were variable across tissues although similar within an organ system. ESR1 ranged from 4.46 to 614 copies/ng RNA (138-fold difference) while ESR2 ranged from 0.154 to 83.1 copies/ng RNA (540-fold). Significant sex differences were broadly absent except for renal ESR1 (female 206 vs. male 614 copies/ng RNA, P < 0.0001) and GPER (62.0 vs. 30.2 copies/ng RNA, P < 0.05) as well as gonadal GPER (5.49 vs. 47.5 copies/ng RNA, P < 0.01), ESR2 (83.1 vs. 0.299 copies/ng RNA, P < 0.01), and CYP19A1 (322 vs. 7.18 copies/ng RNA, P < 0.01). Cardiovascular tissues showed a predominance of ESR1, followed by GPER. In contrast, GPER was the predominant transcript in the brain with similarly low levels of ESR1 and ESR2. CYP19A1 was detected at very low levels except for reproductive tissues and the hippocampus. While the data indicates a lack of sex differences in most tissues, significant differences were found in the range of receptor gene expression across tissues as well as in the receptor profile between organ systems. The data provide a guide for future studies by establishing estrogen receptor expression across multiple tissues using absolute PCR quantification. This knowledge on tissue-specific estrogen receptor profiles will aid the development of hormonal therapies that elicit beneficial effects in specific tissues.

1 January 2019 in Journal of Biomechanics
Verified
Journal Article
Closed access
DCDaniel J. Capone
Daniel J. Capone
GCGabrielle L. Clark
Gabrielle L. Clark
DBDerek Bivona
Derek Bivona
BOBenard O. Ogola
Benard O. Ogola
LDLaurephile Desrosiers
Laurephile Desrosiers
KMKristin S. Miller
Kristin S. Miller

1 September 2018 in Hypertension
Verified
Journal Article
Closed access
BOBenard O Ogola
Benard O Ogola
CACaleb M Abshire
Caleb M Abshire
GCGabrielle L Clark
Gabrielle L Clark
DLDylan J Lawrence
Dylan J Lawrence
MZMargaret Zimmerman
Margaret Zimmerman
SLSarah Lindsey
Sarah Lindsey
Arterial stiffness independently predicts cardiovascular mortality, coronary events, and stroke in hypertensive subjects and is exacerbated in women following menopause. Previously, our laboratory indicated that G protein-coupled estrogen receptor (GPER) plays a protective role in the vasculature. Therefore, the current study assessed the impact of sex and GPER on arterial stiffening in control and hypertensive conditions. We hypothesized that genetic deletion of GPER attenuates sex differences in arterial stiffness. Male and female wildtype (wt) and global GPER knockout (ko) mice (n=46) were used between 16-21 weeks of age. Angiotensin II (Ang II) infusion (700 ng/kg/day for two weeks) was used to induce hypertension, and systolic blood pressure (SBP) was measured using tail cuff plethysmography. Local pulse wave velocity (PWV) within the carotid artery was obtained via high frequency ultrasound in both color Doppler and M-mode. Statistical analysis was performed using two-way ANOVA with Sidak’s multiple comparisons test. Baseline SBP was significantly lower in females (P=0.035) but was not impacted by genotype (P=0.78). Baseline PWV was significantly higher in male versus female wt mice (1.29 vs. 0.804 m/s, P=0.003) but was not different in ko mice (1.25 vs. 1.04 m/s, P=0.22). Ang II infusion significantly increased SBP (P<0.001) and PWV (P<0.001) in all groups, removing any impact of sex or genotype. In addition, significant correlations were found between Doppler and M-mode methods for obtaining carotid PWV (r=0.67, P<0.001) and between PWV and ex vivo carotid wall thickness (r=0.70, P=0.004). In contrast, SBP did not correlate with PWV (P=0.77) or carotid wall thickness (P=0.68). In conclusion, we found that GPER deletion did not impact blood pressure either in normotensive or hypertensive conditions. While arteries from female wt mice were less stiff at baseline, genetic deletion of GPER or Ang II infusion removed this protection independent of blood pressure. Moreover, we found that local carotid PWV provides information on vascular status that could not be obtained via blood pressure. This data indicates that GPER plays an important role in female vascular physiology that is absent in pathological conditions.